Matches in SemOpenAlex for { <https://semopenalex.org/work/W118916852> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W118916852 abstract "Overcoming the excellent barrier properties of the human skin represents the major challenge of this route of delivery. The Metered dose transdermal spray (MDTS®) is a technology developed by Acrux Ltd (AUS). This passive delivery system has the potential to avoid skin irritation. An informed choice of solvents is one of the strategies to design efficient transdermal formulations. Therefore, it is the aim of this thesis to develop optimal volatile formulations and to investigate the enhancement effects of solvents on drug permeation through the skin. A secondary objective is to evaluate the influence of solvent thermodynamic activity on drug permeation and the transport of solvent through skin on drug delivery. Miscibility, solubility, solvent uptake and residence time studies were conducted as a basis for formulation development. The effects of selected solvents on drug permeation were studied using a flow through diffusion cell design, under clinical dosing conditions of use. The influence of formulation related parameters such as solvent dose, supersaturation, combination of solvents and solvent thermodynamic activity, on the amount of ibuprofen permeated through human epidermis was further studied in vitro. The permeation of octyl salicylate, Propylene glycol and polyethylene glycol 200 was monitored by HPLC/UV, GC/MS and LC/MS, respectively, from selected volatile formulations. From these studies, it was found that ibuprofen permeation from all the residual phases studied was solvent dependent. Superior enhancement was obtained using polyethylene glycol 200 followed by propylene glycol, dipropylene glycol and transcutol®. The excipients in which ibuprofen had higher solubility showed a promotion of drug transport. Furthermore, concentration-dependent effect on ibuprofen permeation from solvents was observed. Significant improvements in the permeation of ibuprofen through human skin were achieved using combinations of solvents. The residual phase composed of polyethylene glycol: octyl salicylate (5:1 and 5:10 % (w/v)) were the best solvent/vehicle for ibuprofen permeation. The findings indicate that drug transport appears to be a function not only of the residual phase excipients, but also of the ultimate fate of the excipients after application. Finally, the reported findings demonstrate the potential of volatile formulations to optimise the efficiency of drug delivery to the skin." @default.
- W118916852 created "2016-06-24" @default.
- W118916852 creator A5050825014 @default.
- W118916852 date "2013-04-28" @default.
- W118916852 modified "2023-09-27" @default.
- W118916852 title "Volatile formulations for (trans) dermal drug delivery" @default.
- W118916852 hasPublicationYear "2013" @default.
- W118916852 type Work @default.
- W118916852 sameAs 118916852 @default.
- W118916852 citedByCount "0" @default.
- W118916852 crossrefType "dissertation" @default.
- W118916852 hasAuthorship W118916852A5050825014 @default.
- W118916852 hasConcept C155574463 @default.
- W118916852 hasConcept C178790620 @default.
- W118916852 hasConcept C185592680 @default.
- W118916852 hasConcept C205679159 @default.
- W118916852 hasConcept C2776964284 @default.
- W118916852 hasConcept C2777239854 @default.
- W118916852 hasConcept C2778551929 @default.
- W118916852 hasConcept C2779820397 @default.
- W118916852 hasConcept C2779944601 @default.
- W118916852 hasConcept C2780471494 @default.
- W118916852 hasConcept C41625074 @default.
- W118916852 hasConcept C43617362 @default.
- W118916852 hasConcept C50670333 @default.
- W118916852 hasConcept C55493867 @default.
- W118916852 hasConcept C71924100 @default.
- W118916852 hasConcept C98274493 @default.
- W118916852 hasConceptScore W118916852C155574463 @default.
- W118916852 hasConceptScore W118916852C178790620 @default.
- W118916852 hasConceptScore W118916852C185592680 @default.
- W118916852 hasConceptScore W118916852C205679159 @default.
- W118916852 hasConceptScore W118916852C2776964284 @default.
- W118916852 hasConceptScore W118916852C2777239854 @default.
- W118916852 hasConceptScore W118916852C2778551929 @default.
- W118916852 hasConceptScore W118916852C2779820397 @default.
- W118916852 hasConceptScore W118916852C2779944601 @default.
- W118916852 hasConceptScore W118916852C2780471494 @default.
- W118916852 hasConceptScore W118916852C41625074 @default.
- W118916852 hasConceptScore W118916852C43617362 @default.
- W118916852 hasConceptScore W118916852C50670333 @default.
- W118916852 hasConceptScore W118916852C55493867 @default.
- W118916852 hasConceptScore W118916852C71924100 @default.
- W118916852 hasConceptScore W118916852C98274493 @default.
- W118916852 hasLocation W1189168521 @default.
- W118916852 hasOpenAccess W118916852 @default.
- W118916852 hasPrimaryLocation W1189168521 @default.
- W118916852 hasRelatedWork W1964461500 @default.
- W118916852 hasRelatedWork W1986719808 @default.
- W118916852 hasRelatedWork W1994711494 @default.
- W118916852 hasRelatedWork W2000597498 @default.
- W118916852 hasRelatedWork W2030182281 @default.
- W118916852 hasRelatedWork W2039903558 @default.
- W118916852 hasRelatedWork W2138346823 @default.
- W118916852 hasRelatedWork W2185483721 @default.
- W118916852 hasRelatedWork W2250289161 @default.
- W118916852 hasRelatedWork W2549913054 @default.
- W118916852 hasRelatedWork W2556422203 @default.
- W118916852 hasRelatedWork W2597041097 @default.
- W118916852 hasRelatedWork W2740983561 @default.
- W118916852 hasRelatedWork W2775494557 @default.
- W118916852 hasRelatedWork W2940872955 @default.
- W118916852 hasRelatedWork W2965973711 @default.
- W118916852 hasRelatedWork W2982144557 @default.
- W118916852 hasRelatedWork W3012400627 @default.
- W118916852 hasRelatedWork W2856718473 @default.
- W118916852 hasRelatedWork W2962620255 @default.
- W118916852 isParatext "false" @default.
- W118916852 isRetracted "false" @default.
- W118916852 magId "118916852" @default.
- W118916852 workType "dissertation" @default.